RE-AUTHORING THE LOSSES AND CHALLENGES OF AGING: OLDER INDIVIDUALS’ EXPERIENCES OF LONGTERM GROUP WORK

2015 ◽  
Vol 27 (1) ◽  
pp. 3-19
Author(s):  
Cecile Frankel ◽  
Brenda Solarsh ◽  
Eleanor Ross
Keyword(s):  
Life Expectancy ◽  
Group Work ◽  
Narrative Therapy ◽  
Older Persons ◽  
Senior Citizens ◽  
Cost Effective ◽  
Life Transitions ◽  
Older Individuals ◽  
Documentary Analysis ◽  
Social Group Work

The increase in life expectancy has highlighted the value of group work interventions as a cost-effective way of helping older persons to deal with life transitions. This article describes a group for senior citizens that continued for 18 years. The aim of the study was to undertake a documentary analysis of the facilitator’s process notes and participans’ reflections to ascertain possible reasons for the group’s longevity. These were attributed to the skill of the facilitator and her creative use of programme material and narrative therapy. Recurring themes included loneliness, the fear of dying, and dilemmas about relinquishing control and independence. Findings have implications for the practice of social group work with older persons.

Facing Loss of Vision: The Response of Adults to Visual Impairment

1981 ◽  
Vol 75 (2) ◽  
pp. 41-45 ◽  
Author(s):  
Donna L. Emerson
Keyword(s):  
Group Therapy ◽  
Group Work ◽  
Low Vision ◽  
Psychosocial Problems ◽  
Short Term ◽  
Reactive Depression ◽  
Before And After ◽  
Group Members ◽  
Social Group Work ◽  
Group Experience

Short-term group therapy, using social group work, was utilized to treat the psychosocial problems of two groups of elderly low-vision clients and one group of young adult clients with low vision (N = 24). Group members showed psychosocial movement in three phases: shock, reactive depression, and readjustment. Evaluations measured the change in attitudes before and after group therapy. At the end of therapy, 17 persons, compared to none before the therapy, were at the point of self-acceptance and readjustment. Clinical examples illustrate the interplay of intrapsychic and group-experience factors leading to readjustment.

CHICANOS AND SOCIAL GROUP WORK MODELS

1980 ◽  
Vol 2 (4) ◽  
pp. 331-342 ◽  
Author(s):  
John A. Brown ◽  
Rodolfo Arevalo
Keyword(s):  
Group Work ◽  
Social Group ◽  
Social Group Work

Social Group Work: A Helping Process. Gisela Konopka

1963 ◽  
Vol 37 (3) ◽  
pp. 362-363
Author(s):  
Violet E. Tennant
Keyword(s):  
Group Work ◽  
Social Group ◽  
Helping Process ◽  
Social Group Work

Social Group Work Practice in Rural Areas: The Practitioners Speak

1999 ◽  
Vol 21 (3) ◽  
pp. 19-34 ◽  
Author(s):  
Joanne Gumpert ◽  
Joan E. Saltman
Keyword(s):  
Group Work ◽  
Rural Areas ◽  
Social Group ◽  
Work Practice ◽  
Social Group Work

scholarly journals Cost-Effectiveness of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy in Metastatic Non-Squamous and Squamous NSCLC Patients With PD-L1 Expression ≥ 50%

2022 ◽  
Vol 12 ◽  
Author(s):  
Qiao Liu ◽  
Zhen Zhou ◽  
Xia Luo ◽  
Lidan Yi ◽  
Liubao Peng ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Life Expectancy ◽  
Cost Effective ◽  
Base Case ◽  
First Line ◽  
Term Survival ◽  
First Line Therapy ◽  
Line Therapy ◽  
Nsclc Patients

Objective To compare the cost-effectiveness of the combination of pembrolizumab and chemotherapy (Pembro+Chemo) versus pembrolizumab monotherapy (Pembro) as the first-line treatment for metastatic non-squamous and squamous non-small-cell lung cancer (NSCLC) with PD-L1expression ≥50%, respectively, from a US health care perspective.Material and Methods A comprehensive Makrov model were designed to compare the health costs and outcomes associated with first-line Pembro+Chemo and first-line Pembro over a 20-years time horizon. Health states consisted of three main states: progression-free survival (PFS), progressive disease (PD) and death, among which the PFS health state was divided into two substates: PFS while receiving first-line therapy and PFS with discontinued first-line therapy. Two scenario analyses were performed to explore satisfactory long-term survival modeling.Results In base case analysis, for non-squamous NSCLC patients, Pembro+Chemo was associated with a significantly longer life expectancy [3.24 vs 2.16 quality-adjusted life-years (QALYs)] and a substantially greater healthcare cost ($341,237 vs $159,055) compared with Pembro, resulting in an ICER of $169,335/QALY; for squamous NSCLC patients, Pembro+Chemo was associated with a slightly extended life expectancy of 0.22 QALYs and a marginal incremental cost of $3,449 compared with Pembro, resulting in an ICER of $15,613/QALY. Our results were particularly sensitive to parameters that determine QALYs. The first scenario analysis yielded lower ICERs than our base case results. The second scenario analysis founded Pembro+Chemo was dominated by Pembro.Conclusion For metastatic non-squamous NSCLC patients with PD-L1 expression ≥50%, first-line Pembro+Chemo was not cost-effective when compared with first-line Pembro. In contrast, for the squamous NSCLC patient population, our results supported the first-line Pembro+Chemo as a cost-effective treatment. Although there are multiple approaches that are used for extrapolating long-term survival, the optimal method has yet to be determined.

scholarly journals Neighborhood Disadvantage and Active, Disabled and Total Life Expectancy Among Community-living Older Persons

2021 ◽  
Author(s):  
Thomas M. Gill ◽  
Emma X. Zang ◽  
Terrence E. Murphy ◽  
Linda Leo-Summers ◽  
Evelyne A. Gahbauer ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Life Expectancy ◽  
Older Persons ◽  
Neighborhood Disadvantage ◽  
Community Living ◽  
Remaining Life ◽  
Disadvantaged Group ◽  
Individual Level ◽  
Total Life Expectancy ◽  
Total Life

AbstractBackgroundNeighborhood disadvantage is a novel social determinant of health that could adversely affect the functional well-being and longevity of older persons. We evaluated whether estimates of active, disabled and total life expectancy differ on the basis of neighborhood disadvantage after accounting for individual-level socioeconomic characteristics and other prognostic factors.MethodsWe used data on 754 community-living older persons from South Central Connecticut, who completed monthly assessments of disability from 1998 to 2020. Scores on the area deprivation index were dichotomized at the 80th state percentile to distinguish neighborhoods that were disadvantaged (81-100) from those that were not (1-80).ResultsWithin 5-year age increments from 70 to 90, active and total life expectancy were consistently lower in participants from neighborhoods that were disadvantaged versus not disadvantaged, and these differences persisted and remained statistically significant after adjustment for individual-level race/ethnicity, education, income, and other prognostic factors. At age 70, adjusted estimates (95% CI) for active and total life expectancy (in years) were 12.3 (11.5-13.1) and 15.0 (13.8-16.1) in the disadvantaged group and 14.2 (13.5-14.7) and 16.7 (15.9-17.5) in the non-disadvantaged group. At each age, participants from disadvantaged neighborhoods spent a greater percentage of their projected remaining life disabled, relative to those from non-disadvantaged neighborhoods, with adjusted values (SE) ranging from 17.7 (0.8) vs. 15.3 (0.5) at age 70 to 55.0 (1.7) vs. 48.1 (1.3) at age 90.ConclusionsLiving in a disadvantaged neighborhood is associated with lower active and total life expectancy and a greater percentage of projected remaining life disabled.

Sign in / Sign up

Export Citation Format

Share Document